Ocular gene transfer in the spotlight: Implications of newspaper content for clinical communications

BMC Medical Ethics

Volumn 15, Issue 1, 2014, Pages

  Benjaminy, Shelly ^a   Bubela, Tania ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ethics; Gene therapy; Gene transfer; Informed consent; Media; Newspaper coverage; Therapeutic misconception

Indexed keywords

BLINDNESS; CANADA; DOCTOR PATIENT RELATION; ETHICS; GENE THERAPY; GENE TRANSFER; GENETICS; GREAT BRITAIN; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MASS MEDIUM; MEDICAL RESEARCH; METHODOLOGY; OPTIMISM; PROCEDURES; PUBLICATION; RETINAL DISEASES; RISK; TRANSLATIONAL RESEARCH; UNITED STATES;

BIOMEDICAL RESEARCH; BLINDNESS; CANADA; COMMUNICATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GREAT BRITAIN; HUMANS; INFORMED CONSENT; MASS MEDIA; NEWSPAPERS AS TOPIC; OPTIMISM; PHYSICIAN-PATIENT RELATIONS; RESEARCH DESIGN; RETINAL DISEASES; RISK; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84904273421     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-15-58     Document Type: Article

References (67)

1. Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency. Wilson JM, Mol Genet Metab 2009 96 4 151 157
2. The death of Jesse Gelsinger: new evidence of the influence of money and prestige in human research. Wilson RF, Am J Law Med 2010 36 2-3 295 325
3. Gene therapy oversight: lessons for nanobiotechnology. Wolf SM, Gupta R, Kohlhepp P, J Law Med Ethics 2009 37 01 659 684
4. Gene transfer in the post-Gelsinger era. Smith L, Byers JF, JONAS Healthc Law Ethics Regul 2002 4 4 104 110
5. Public trust and research a decade later: what have we learned since Jesse Gelsinger's death? Yarborough M, Sharp RR, Mol Genet Metab 2009 97 1 4 5
6. Effect of gene therapy on visual function in Leber's congenital amaurosis. Bainbridge JWB, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR, N Engl J Med 2008 358 21 2231 2239 (Pubitemid 351724452)
7. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, Jacobson SG, Hum Gene Ther 2008 19 10 979 990
8. Safety and efficacy of gene transfer for Leber's congenital amaurosis. Maguire AM, Simonelli F, Pierce EA, Pugh EN, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell'Osso L, Hertle R, Ma J, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, et al. N Engl J Med 2008 358 21 2240 2248 (Pubitemid 351724453)
9. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Simonelli F, Maguire AM, Testa F, Pierce EA, Mingozzi F, Bennicelli JL, Rossi S, Marshall K, Banfi S, Surace EM, Sun J, Redmond TM, Zhu X, Shindler KS, Ying G, Ziviello C, Acerral C, Wright JF, McDonnell JW, High KA, Bennett J, Auricchio A, Mol Ther 2010 18 3 643 650
10. Prospects for retinal gene replacement therapy. Smith AJ, Bainbridge JW, Ali RR, Trends Genet 2009 25 4 156 165
11. Leber congenital amaurosis: from darkness to spotlight. Kaplan J, Ophthalmic Genet 2008 29 3 92 98
12. My child has Leber congenital amaurosis: why is he/she not eligible for gene therapy trials? Heon E, J AAPOS 2009 13 6 533 534
13. Science and the sources of hype. Caulfield T, Condit C, Public Health Genomics 2012 15 3-4 209 217
14. Are genetic tests adequately regulated? Holtzman NA, Science 1999 286 5439 409
15. Media discourse and public opinion on nuclear power: a constructionist approach. Gamson WA, Modigliani A, Am J of Sociol 1989 95 1 1 37
16. Understanding citizen perceptions of science controversy: bridging the ethnographic survey research divide. Nisbet M, Goidel R, Public Underst Sci 2007 16 4 421 440
17. Framing science the stem cell controversy in an age of press/politics. Nisbet MC, Brossard D, Kroepsch A, IJPP 2003 8 2 36 70 (Pubitemid 36719570)
18. The stem cell research environment: a patchwork of patchworks. Caulfield T, Zarzeczny A, McCormick J, Bubela T, Critchley C, Einsiedel E, Galipeau J, Harmon S, Huynh M, Hyun I, Illes J, Isasi R, Joly Y, Laurie G, Lomax G, Longstaff H, Mcdonald M, Murdoch C, Ogbogu U, Owen-Smith J, Pattinson S, Premji S, von Tigerstrom B, Winickoff DE, Stem Cell Rev 2009 5 2 82 88
19. Scientific sensationalism in American and British press coverage of therapeutic cloning. Jensen E, J Mass Commun Q 2012 89 1 40 54
20. Science communication reconsidered. Bubela T, Hyde-Lay R, Lane S, Ogbogu U, Ouellette C, Nisbet MC, Borchelt R, Brunger F, Critchley C, Einsiedel E, Geller G, Gupta A, Hampel J, Hyde-Lay R, Jandciu EW, Jones SA, Kolopack P, Lane S, Lougheed T, Nerlich B, Ogbogu U, O'Riordan K, Ouellette C, Spear M, Strauss S, Thavaratnam T, Willemse L, Caulfield T, Nat Biotechnol 2009 27 6 514 518
21. Funding source and research report quality in nutrition practice-related research. Myers EF, Parrott JS, Cummins DS, Splett P, PLoS One 2011 6 12 28437
22. Journalists and conflicts of interest in science: beliefs and practices. Cook DM, Boyd EA, Grossmann C, Bero LA, Ethics Sci Environ Polit 2009 9 33 40
23. The ethics of expectations: biobanks and the promise of personalised medicine. Petersen A, Monash Bioeth Rev 2009 28 1 1 12
24. Quantitative analysis of ethical issues in phase I trials: a survey interview study of 144 advanced cancer patients. Daugherty CK, Banik DM, Janish L, Ratain MJ, IRB 2000 22 3 6 14
25. Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Pentz RD, Harvey RD, Owonikoko T, Khuri FR, White M, Farmer ZL, Liu Y, Lewis C, Dashevskaya O, Cancer 2012 118 18 4571 4578
26. Alliance for audited media. http://www.auditedmedia.com
27. ClinicalTrials.gov. National Institutes of Health, http://www. clinicaltrials.gov/ct2/results/map?term=gene+therapy
28. Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers. Bubela TM, Caulfield TA, CMAJ 2004 170 9 1399 1407 (Pubitemid 38594632)
29. Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals. Bubela T, Boon H, Caulfield T, BMC Med 2008 6 1 35
30. How geneticists can help reporters to get their story right. Condit CM, Nat Rev Genet 2007 8 10 815 820 (Pubitemid 47432550)
31. The quality of media reports on discoveries related to human genetic diseases. Holtzman NA, Bernhardt BA, Mountcastle-Shah E, Rodgers JE, Tambor E, Geller G, Community Genet 2005 8 3 133 144 (Pubitemid 41197096)
32. Framing Science: A New Paradigm in Public Engagement. Nisbet MC, Understanding Science: New Agendas in Science Communication New York: Taylor and Francis, Kahlor L, Stout P, 2009 40 67
33. "Is a cure in my sight?": Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials. Benjaminy S, MacDonald I, Bubela T, Genet Med 2014 16 5 379 385
34. Neuendorf KA, The Content Analysis Guidebook Thousand Oaks, California: Sage Publications 2002
35. Campbell J, Science Gives Blind Dogs Sight: 'First Fruit of Genetic revolution' Raises Hope for Fighting Other Genetic Diseases Ottawa: The Ottawa Citizen 2001
36. Sample I, Gene Therapy Aimed at Restoring Sight for 30,000 People London: The Guardian 2007
37. Mick H, Gene Therapy Shines Light on Blindness Toronto: The Globe and Mail 2008
38. Willey J, Blind Will 'see' Within a few Days of Gene Therapy London: The Daily Express 2008
39. Sensationalism in the media: when scientists and journalists may be complicit collaborators. Ransohoff DF, Ransohoff RM, Eff Clin Pract 2001 4 4 185 188
40. Hedgecoe A, The Politics of Personalised Medicine: Pharmacogenetics in the Clinic Cambridge: Cambridge University Press 2004
41. Distorting genetic research about cancer: from bench science to press release to published news. Brechman JM, Lee CJ, Cappella JN, J Commun 2011 61 3 496 513
42. Chinese newspaper coverage of (unproven) stem cell therapies and their providers. Ogbogu U, Du L, Rachul C, Bélanger L, Caulfield T, Stem Cell Rev 2013 9 2 1 8
43. Public expectations of gene therapy scientific futures and their performative effects on scientific citizenship. Horst M, Sci Technol Hum Values 2007 32 2 150 171
44. Public opinion and trust in scientists: the role of the research context, and the perceived motivation of stem cell researchers. Critchley CR, Public Underst Sci 2008 17 3 309 327
45. Kimmelman J, Gene Transfer and the Ethics of First-in-Human Research: Lost in Translation Cambridge: Cambridge University Press 2010
46. The influence of presumed media influence on news about science and scientists. Tsfati Y, Cohen J, Gunther AC, Sci Commun 2011 33 2 143 166
47. The human drama of genetics: 'hard' and 'soft' media representations of inherited breast cancer. Henderson L, Kitzinger J, Sociol Health Illn 1999 21 5 560 578
48. News framing of autism understanding media advocacy and the combating Autism Act. McKeever BW, Sci Commun 2013 35 2 213 240
49. Forecasting science futures: legitimising hope and calming fears in the embryo stem cell debate. Kitzinger J, Williams C, Soc Sci Med 2005 61 3 731 740 (Pubitemid 40724616)
50. Biofantasies: genetics and medicine in the print news media. Petersen A, Soc Sci Med 2001 52 8 1255 1268 (Pubitemid 32101450)
51. Mediating subpolitics in US and UK science news. Jensen E, Public Underst Sci 2012 21 1 68 83
52. What's next for science communication? Promising directions and lingering distractions. Nisbet MC, Scheufele DA, Am J Bot 2009 96 10 1767 1778
53. Contemporary neuroscience in the media. Racine E, Waldman S, Rosenberg J, Illes J, Soc Sci Med 2010 71 4 725 733
54. Understanding the impact of commercialization on public support for scientific research: is it about the funding source or the organization conducting the research? Critchley CR, Nicol D, Public Underst Sci 2011 20 3 347 366
55. Costs and benefits of stem cell research and treatment: media presentation and audience understanding in Hungary. Vicsek L, Sci Commun 2011 33 3 309 340
56. Direct-to-consumer genetic testing: perceptions, problems, and policy responses. Caulfield T, McGuire AL, Annu Rev Med 2012 63 23 33
57. What is 'public opinion' about genetics? Condit C, Nat Rev Genet 2001 2 10 811 815 (Pubitemid 33685578)
58. Portrayal of psychiatric genetics in Australian print news media, 1996-2009. Wilde A, Bonfiglioli C, Meiser B, Mitchell PB, Schofield PR, Med J Aust 2011 195 7 401 404
59. Utilizing social media to study information-seeking and ethical issues in gene therapy. Robillard JM, Whiteley L, Johnson TW, Lim J, Wasserman WW, Illes J, J Med Internet Res 2013 15 3 44
60. Gene therapy restores vision in a canine model of childhood blindness. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM, Jacobson SG, Hauswirth WW, Bennett J, Nat Genet 2001 28 1 92 95 (Pubitemid 32405824)
61. The therapeutic misconception: informed consent in psychiatric research. Appelbaum PS, Roth LH, Lidz C, Int J Law Psychiatry 1982 5 3-4 3 4
62. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. Horng S, Grady C, IRB 2003 25 1 11 16 (Pubitemid 41585063)
63. Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. Pentz RD, Flamm AL, Sugarman J, Cohen MZ, Ayers GD, Herbst RS, Abbruzzese JL, J Clin Oncol 2002 20 18 3785 3791
64. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Jacobson SG, Aleman TS, Cideciyan AV, Sumaroka A, Schwartz SB, Windsor EAM, Traboulsi EI, Heon E, Pittler SJ, Milam AH, Maguire AM, Placzewski K, Stone EM, Bennett J, Proc Natl Acad Sci U S A 2005 102 17 6177 6182 (Pubitemid 40594274)
65. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Cideciyan AV, Jacobson SG, Beltran WA, Sumaroka A, Swider M, Iwabe S, Roman AJ, Olivares MB, Schwartz SB, Komáromy AM, Hauswirth WW, Aguirre GD, Proc Natl Acad Sci U S A 2013 110 6 517 E525
66. Ethics of cancer gene transfer clinical research. Kimmelman J, Methods Mol Biol 2009 542 423 445
67. In pursuit of "informed hope" in the stem cell discourse. Reimer J, Borgelt E, Illes J, Am J Bioeth 2010 10 5 31 32